Skip to Main Content
Title
International pharmaceutical spending controls: France, Germany, Sweden, and the United Kingdom.
First Author
Gross, David J
Date of Pub
1994 Spring
Pages
127-140
Volume
15
Issue
3
Other Authors
Glavin, Sarah L; Perez, James; Ratner, Jonathan
Abstract
France, Germany, Sweden, and the United Kingdom each use different types of policies for controlling prescription drug spending. Until recent years, these policies have relied heavily on regulating prices charged by drug manufacturers, with different systems providing varying degrees of pricing freedom. While these policies appear to have brought some degree of price restraint, they have not prevented continued growth in prescription drug spending. As a result, each country is supplementing its policies with measures aimed at physicians and consumers and targeted at reducing a perceived over-utilization of pharmaceutical products.
Abstract Continued
N/A
MeSH
Comparative Study : Cost Control/legislation & jurisprudence : Cost Sharing : Drug Costs/legislation & jurisprudence : Drug Industry/economics/legislation & jurisprudence : Drug Utilization/trends : Eligibility Determination : France : Germany : Great Britain : Health Policy/economics/legislation & jurisprudence : Inflation, Economic/trends : Insurance, Pharmaceutical Services/utilization : National Health Programs/economics : State Medicine/economics
NTIS Number
PB95-123477